Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults

Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults

Background Use of psychostimulants and relative drugs has increased worldwide in treatment of attention-deficit hyperactivity disorder (ADHD) in adolescents and adults. Recent studies suggest a potential association between use of psychostimulants and psychotic symptoms. The risk may not be the same...

Full description

Bibliographic Details
Main Authors:	François Montastruc, Vanessa Rousseau, Agnes Sommet, Alexis Revet, Genevieve Durrieu, Jacques Hamard, Philippe Garcia, Antoine Yrondi
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-04-01
Series:	BMJ Mental Health
Online Access:	https://ebmh.bmj.com/content/27/1/e300876.full

Similar Items

Atomoxetine and Methylphenidate Treatment in ADHD
by: Snircova E., et al.
Published: (2015-05-01)

Characterization of Amphetamine, Methylphenidate, Nicotine, and Atomoxetine on Measures of Attention, Impulsive Action, and Motivation in the Rat: Implications for Translational Research
by: Guy A. Higgins, et al.
Published: (2020-04-01)

Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system
by: Wei Wei, et al.
Published: (2023-08-01)

Amphetamines, atomoxetine and the risk of serious cardiovascular events in adults.
by: Hedi Schelleman, et al.
Published: (2013-01-01)

Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
by: Shiho Suzuki, et al.
Published: (2020-05-01)

Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy
by: Bro SP, et al.
Published: (2015-01-01)

Functional outcomes of extended-release methylphenidate and atomoxetine in children: retrospective chart analysis
by: Armagan Aral, et al.
Published: (2022-08-01)

Daily methylphenidate and atomoxetine treatment impacts on clock gene protein expression in the mouse brain.
by: Baird, A, et al.
Published: (2013)

Methylphenidate and atomoxetine prescribing trends in children in the Western Cape Province of South Africa, 2005–2013
by: Liezl Joubert, et al.
Published: (2018-07-01)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
by: Joseph A, et al.
Published: (2016-03-01)

Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis
by: Hanwella Raveen, et al.
Published: (2011-11-01)

Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States
by: Sneha M. Vaddadi, et al.
Published: (2021-12-01)

A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain
by: Dilla Tatiana, et al.
Published: (2009-04-01)

Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy
by: Yoko Nakanishi, et al.
Published: (2017-05-01)

Antipsychotics for Amphetamine Psychosis. A Systematic Review
by: Dimy Fluyau, et al.
Published: (2019-10-01)

Atomoxetine might be more effective in improving sluggish cognitive tempo symptoms after switching from methylphenidate: A case report
by: Akın Tahıllıoğlu, et al.
Published: (2021-02-01)

Protective effects of amphetamine and methylphenidate against dopaminergic neurotoxicants in SH-SY5Y cells
by: Patrícia Carneiro, et al.
Published: (2024-01-01)

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents
by: S King, et al.
Published: (2006-07-01)

Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?
by: Bramness Jørgen G, et al.
Published: (2012-12-01)

Mobile health in the specific management of first-episode psychosis: a systematic literature review
by: Claire Maechling, et al.
Published: (2023-06-01)

Prenatal Drug Exposure in Children With a History of Neuropsychiatric Care: A Nested Case-Control Study
by: Justine Benevent, et al.
Published: (2022-03-01)

Cancer risk of anti-TNF-α at recommended doses in adult rheumatoid arthritis: a meta-analysis with intention to treat and per protocol analyses.
by: Guillaume Moulis, et al.
Published: (2012-01-01)

Atomoxetine Induced Obsessive-Compulsive Disorder
by: Mengühan Araz Altay
Published: (2019-01-01)

Reassessment of amphetamine- and phencyclidine-induced locomotor hyperactivity as a model of psychosis-like behavior in rats
by: Snezana Kusljic, et al.
Published: (2022-01-01)

Suspected Suicide Attempt and Intentional Misuse Cases Aged 50+ Involving Amphetamine or Methylphenidate and Medical Outcomes: Associations with Co-Used Other Substances
by: Namkee G. Choi, et al.
Published: (2023-07-01)

Off-label use of atomoxetine in adults: is it safe?
by: Peter Silverstone, et al.
Published: (2012-07-01)

A critical appraisal of atomoxetine in the management of ADHD
by: Childress AC
Published: (2015-12-01)

Atomoxetine in abstinent cocaine users: Sex differences
by: Elise E. DeVito, et al.
Published: (2017-10-01)

The effect of atomoxetine on random and directed exploration in humans.
by: Christopher M Warren, et al.
Published: (2017-01-01)

Therapeutic and Preventive Use of Video Games in Child and Adolescent Psychiatry: A Systematic Review
by: Darius Zayeni, et al.
Published: (2020-02-01)

Atomoxetine Induced Seperation Anxiety: A Case Report
by: Gonca Gul Celik, et al.
Published: (2013-06-01)

Is atomoxetine effective in some comorbid mental disorders in ADHD?
by: Cesneková D., et al.
Published: (2016-09-01)

Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
by: Jung‐Ick Byun, et al.
Published: (2020-01-01)

Dangerous Amphetamines
by: Abd Razak, Dzulkifli
Published: (1996)

Brief psychosis induced by methylphenidate in a child with attention deficit disorder: a case report and literature review
by: Juan Carlos Martínez-Aguayo, et al.
Published: (2017-06-01)

Methylphenidate Abuse
by: J Gordon Millichap
Published: (1994-11-01)

Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians
by: Lehmann Martin, et al.
Published: (2009-08-01)

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
by: Paul Hammerness, et al.
Published: (2009-03-01)

Probable emergence of symptoms of trichotillomania by atomoxetine: a case report
by: Hamza Ayaydın
Published: (2019-04-01)

Atomoxetine associated red ear: A case report (eng)
by: Hande Ayraler Taner, et al.
Published: (2020-04-01)